Friday, April 18, 2025 9:00:51 PM
Smitty, I believe that management does have a plan, and I think that they have thought it out well. Unfortunately it starts with UK approval and that is taking longer than expected, but hopefully it is about to happen. Of course another key is the EDEN Unit, and perhaps we will get an update on that in the near future as well.
As an old IMGN investor I know that they operated in much the same way. When told something was happening soon we found it sometimes meant over a year. When quoting the CEO we'd spell it backwards NOOS. He knew we were doing it, at one point he chatted with us and got in trouble with the SEC. for doing so.
My point is that many companies are little different from NWBO and some that are, like CVM, express their beliefs that their one drug, developed a few decades ago is the answer to a wide variety of diseases, only one in trials at a time. After each failure they simply do a search and replace their PR's inserting a new disease that they feel equally certain they'll cure.
I think management is doing it right and while frustrating in time it will pay off well for longs. Shorts who don't clear their positions are looking to get burned.
Gary
As an old IMGN investor I know that they operated in much the same way. When told something was happening soon we found it sometimes meant over a year. When quoting the CEO we'd spell it backwards NOOS. He knew we were doing it, at one point he chatted with us and got in trouble with the SEC. for doing so.
My point is that many companies are little different from NWBO and some that are, like CVM, express their beliefs that their one drug, developed a few decades ago is the answer to a wide variety of diseases, only one in trials at a time. After each failure they simply do a search and replace their PR's inserting a new disease that they feel equally certain they'll cure.
I think management is doing it right and while frustrating in time it will pay off well for longs. Shorts who don't clear their positions are looking to get burned.
Gary
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
